Torrent Pharmaceuticals Limited CC-Mar24.pdf · 2024-05-24
Just two quick ones. One, if at all that's possible for the Brazil in terms of the constant currency growth, the 12%-13% that we have reported in this year, is there a way to sort of split that into let's say pricing versus volume or anything that's possible for us to understand how that market is progressing, because the new introductions or the new product launches would be a substantial part of the growth over there, given how the market is behaving. So, anything in that aspect?
And you mentioned on your previous comments that Brazil should possibly do sort of a 14 %- 15% growth, if I am not wrong in FY25?